“Dr. Nagel, you kind of answered in your presentation the FDA’s efforts towards breast implant safety registry’s tracking but maybe I could just ask a clarification question based on your presentation, with regards to the [FDA] update from September 8th…

For Immediate Release: September 08, 2022 Statement From: Today, the U.S. Food and Drug Administration issued a safety communication informing patients and providers about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast…

U.S. cases of a cancer linked to breast implants may be well more than double what the FDA previously estimated, says new research from Columbia University. Breast anaplastic large-cell lymphoma (ALCL), is a cancer linked to both smooth and textured…

SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augmentation in women at least…

Washington, D.C., October 27, 2021—(FDA) Today, the U.S. Food and Drug Administration took several new actions to strengthen breast implant risk communication and help those who are considering breast implants make informed decisions. First, the agency issued orders restricting the…

Washington, D.C., September 28, 2020—(FDA) Today, the U.S. Food and Drug Administration issued the final guidance, “Breast Implants – Certain Labeling Recommendations to Improve Patient Communication,” as part of the agency’s effort to help improve the information available to patients…